Cotización Aerie Pharmaceuticals, Inc.
Acciones
AERI
US00771V1089
Farmacéuticos
Directores | Puesto | Edad | Desde |
---|---|---|---|
David Endicott
CEO | Chief Executive Officer | 58 | 21/11/22 |
Andrew Allen
CMP | Compliance Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 01/03/22 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ian Bell
BRD | Director/Board Member | 54 | 21/11/22 |
Chairman | 57 | 21/11/22 | |
Jonathan Balch
BRD | Director/Board Member | - | 21/11/22 |
Nombre | Peso | AuM | Varia. 1 de ene. | Calificación inversor |
---|---|---|---|---|
0.02% | 464 M€ | -.--% |
Varia. 1 de ene. | Capi. | |
---|---|---|
+33,46 % | 701 mil M | |
+26,24 % | 571 mil M | |
+0,93 % | 381 mil M | |
+21,03 % | 334 mil M | |
+17,51 % | 319 mil M | |
+0,74 % | 210 mil M | |
+2,95 % | 210 mil M | |
-6,05 % | 201 mil M | |
-3,61 % | 157 mil M |